SuperArray Picks PCR over Microarrays As It Enters miRNA-Expression Market

Rather than go head to head against firms like Invitrogen or Exiqon that sell spotted miRNA microarrays, SuperArray has decided to sell miRNA content via PCR performed in microtiter plates, an older format that the company said is superior to microarrays because of its “dynamic range and the sensitivity of RT-PCR.”

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.